Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

DHT, a testosterone byproduct, causes male pattern baldness.

Minoxidil helps grow longer, thicker hair in bald scalps of stumptailed macaques, and early treatment is more effective.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Skin problems are common and important signs of eating disorders and treating the eating disorder can improve these skin conditions.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Certain hormone treatments can improve acne and related conditions in women.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that more research is needed to fully understand the causes of PCOS.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.